Approval · Notice of Compliance 8796 · 2007
SUPREFACT: Notice of Compliance 8796
Issued May 22, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8796
- Date
- May 22, 2007
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the dosage and administration section of the product monograph as well as other revisions to the product monograph
- Therapeutic class
- Luteinizing hormone-releasing hormone (lhrh) analogue
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUPREFACT | Not yet assigned | — |
Medicinal ingredients
- BUSERELIN ACETATE 1 MG per ML